0001209191-21-059512.txt : 20211005 0001209191-21-059512.hdr.sgml : 20211005 20211005165311 ACCESSION NUMBER: 0001209191-21-059512 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211001 FILED AS OF DATE: 20211005 DATE AS OF CHANGE: 20211005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crystal Adam CENTRAL INDEX KEY: 0001825445 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39567 FILM NUMBER: 211307440 MAIL ADDRESS: STREET 1: C4 THERAPEUTICS, INC. STREET 2: 490 ARSENAL WAY, SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: C4 Therapeutics, Inc. CENTRAL INDEX KEY: 0001662579 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 475617627 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: (617) 231-0700 MAIL ADDRESS: STREET 1: 490 ARSENAL WAY STREET 2: SUITE 200 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-10-01 0 0001662579 C4 Therapeutics, Inc. CCCC 0001825445 Crystal Adam C/O C4 THERAPEUTICS, INC. 490 ARSENAL WAY #200 WATERTOWN MA 02472 0 1 0 0 Chief Medical Officer Common Stock 2021-10-01 4 M 0 15000 4.98 A 15000 D Common Stock 2021-10-01 4 S 0 1712 44.2502 D 13288 D Common Stock 2021-10-01 4 S 0 8176 45.3233 D 5112 D Common Stock 2021-10-01 4 S 0 5112 45.9935 D 0 D Stock Option (Right to Buy) 4.98 2021-10-01 4 M 0 15000 0.00 D 2030-07-02 Common Stock 15000 168108 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on January 21, 2021. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.57 to $44.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.85 to $45.845. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.89 to $46.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020. /s/ Jolie M. Siegel, Attorney-in-Fact 2021-10-05